Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 5-(4-Fluorophenyl)-2,4-dihydro-3H-pyrazol-3-one | HCID 4778792 | — |
| Reactant | 4-Chloro-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazoline | HCID 11823941 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ammonium Chloride | HCID 25517 | — |
| Product | HCID 17942763 | HCID 17942763 | 48% |
Reaction Steps
3-(4-Fluorophenyl)-4,5-dihydro-1H-pyrazol-5-one (222 mg, 1.25 mmol) was added in portions over 10 minutes to a suspension of sodium hydride (50 mg, 1.25 mmol, prewashed with hexane) in DMF (3 ml) under nitrogen. After stirring for 20 minutes at ambient temperature, 4-chloro-6-methoxy-7-(3-morpholinopropoxy)quinazoline (169 mg, 0.5 mmol), (prepared as described for the starting material in Example 2), was added and the mixture was heated at 60° C. for 1 hour. After cooling, the mixture was diluted with aqueous ammonium chloride solution and ether was added. The precipitate was collected by filtration, washed with water, and dried under vacuum. The solid was dissolved in methylene chloride/methanol (1/1) and 4M ethereal hydrogen chloride (0.5 ml) was added. After removal of the solvent by evaporation, the solid was triturated with ether, collected by filtration and dried under vacuum to give 4-(5-(4-fluorophenyl)pyrazol-3-yloxy)-6-methoxy-7-(3-morpholinopropoxy)quinazoline hydrochloride (115 mg, 48%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07262201B1 |
|---|
| Source dataset | uspto-grants-2007_08 |
|---|
| ORD ID | ord-0c7f3ab9561641c2a32dfeeb8e5c34fd |
|---|
| Source note | uspto-grants-2007_08 |
|---|